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Abstract
Irritable bowel syndrome (IBS) is a prevalent functional disorder characterized by abdominal pain
and hypervigilance to gastrointestinal sensations. We hypothesized that mindfulness training
(MT), which promotes nonreactive awareness of emotional and sensory experience, may target
underlying mechanisms of IBS including affective pain processing and catastrophic appraisals of
gastrointestinal sensations. Seventy five female IBS patients were randomly assigned to
participate in either 8 weeks of MT or a social support group. A theoretically grounded,
multivariate path model tested therapeutic mediators of the effect of MT on IBS severity and
quality of life. Results suggest that MT exerts significant therapeutic effects on IBS symptoms by
promoting nonreactivity to gut-focused anxiety and catastrophic appraisals of the significance of
abdominal sensations coupled with a refocusing of attention onto interoceptive data with less
emotional interference. Hence, MT appears to target and ameliorate the underlying pathogenic
mechanisms of IBS.
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How do psychological interventions ameliorate distressing somatic symptoms? Although
several decades of clinical research have demonstrated the efficacy of psychological
therapies for mind-body conditions since Engel’s (1977) articulation of the biopsychosocial
paradigm, the therapeutic mechanisms of many such treatments remain unspecified. One
such condition, irritable bowel syndrome (IBS), remains refractory for a substantial number
of patients receiving usual medical care, yet seems to be especially tractable to
psychological treatments like cognitive behavior therapy (CBT) (Lackner et al., 2007),
clinical hypnosis (Whorwell et al., 1984), and mindfulness-based therapy (Gaylord et al.,
2011; Ljotsson et al., 2010). IBS is a functional gastrointestinal (GI) disorder characterized
by abdominal pain, heightened visceral sensitivity, and in some cases, altered
gastrointestinal motility, and these symptoms are often reciprocally linked to stress, anxiety,
catastrophic thinking, and negative affect (Mayer & Tillisch, 2010). Given the established
physiological linkages between the enteric and central nervous systems, enhanced
responsiveness to psychosocial stressors and perturbations of visceral homeostasis may
result in exaggerated autonomic reactions, altered bowel habits, hyperalgesia, and
hypervigilance towards interoceptive signals from the gut (Mayer, 1999). Furthermore,
selective attention to visceral sensations and heightened threat appraisals may maintain IBS
symptoms in lieu of present stressors (Naliboff et al., 2008). Thus, central and peripheral
systems interact to produce and preserve the pathogenic processes underpinning IBS.
Given the substantial contribution of psychological factors to IBS symptomatology, the
therapeutic benefit of psychological interventions for IBS has been thought to derive from
reductions in comorbid psychological distress (Lackner et al., 2007). However, path
analyses of CBT as a treatment for IBS conducted by Lackner and colleagues (2007) found
no evidence for such a presumed meditational effect. Instead, in their model CBT was
directly associated with improvement in GI symptoms which, in turn, was associated with
increased quality of life. Enhancements in quality of life were reciprocally linked with
reductions in psychological distress, but no evidence was found for a direct effect of CBT on
psychological distress. However, a study by Jones et al. (2011) identified an indirect effect
of CBT on IBS symptoms, such that improvement in mood led to the perception of
improved IBS symptoms. Thus, the therapeutic mechanisms of CBT on IBS severity remain
unclear.
Apart from CBT, the other most commonly tested psychological therapy for IBS is clinical
hypnosis. In studies of hypnosis, significant reductions in maladaptive IBS-related
cognitions, affective symptoms, and somatization are frequently reported along with
improvement in gastrointestinal symptoms (Gonsalkorale et al., 2004; Palsson et al., 2002).
These psychological changes may mediate the robust therapeutic effects of clinical hypnosis
on IBS observed across multiple clinical trials (Miller & Whorwell, 2009).
Like CBT and clinical hypnosis, mindfulness training (MT) may hold promise for IBS
sufferers who remain highly symptomatic in spite of the best efforts of conventional medical
care. MT, whether provided by secular programs such as Mindfulness-Based Stress
Reduction (MBSR) or through more traditional Buddhist practices, involves the cultivation
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of a state characterized by an attentive and nonjudgmental metacognitive monitoring of
moment-by-moment cognition, emotion, perception, and sensation without fixation on
thoughts of past and future (Garland, 2007). According to some theoretical accounts (e.g.,
Chambers, Gullone, & Allen, 2009; Davidson, 2010; Garland et al., 2010) the repeated
practice of generating the state of mindfulness leads to the development of trait or
dispositional mindfulness, i.e., the propensity towards exhibiting nonjudgmental,
nonreactive awareness of one’s thoughts, emotions, experiences, and actions in everyday life
(Baer, Smith, Hopkins, Krietemeyer, & Toney, 2006). In support of this notion, Carmody &
Baer (2008) found that the therapeutic effects of participation in MBSR are mediated by
increases in dispositional mindfulness. Given the growing body of research demonstrating
the therapeutic effects of MT on stress and pain symptoms (Grossman et al., 2004;
Rosenzweig et al., 2010) in chronic functional disorders such as fibromyalgia and
depression (Kaplan et al., 1993; Teasdale et al., 2000), MT may be an effective treatment for
IBS, a condition often rendered refractory by stress (Lea & Whorwell, 2004).
Findings from our recent randomized controlled trial (RCT) demonstrate that MT results in
statistically and clinically significant improvements in bowel symptoms, affective
symptoms, and IBS-related quality-of-life (Gaylord et al., 2011). In this trial, patients
receiving MT exhibited significantly larger reductions in IBS severity after treatment (an
average 38.2% reduction in symptom scores) and significantly greater improvements in
quality of life than those participating in a support group. These findings converge with
those of a RCT of an internet-delivered, mindfulness- and exposure-based treatment for IBS,
which also identified significant therapeutic effects on IBS symptoms (Ljotsson et al., 2010).
What processes might account for the ameliorative effects of MT on IBS symptomatology?
During the development of our recently completed RCT, we theorized that the following
therapeutic mechanisms may mediate the effects of MT on IBS symptomatology. First,
recurrent mindfulness practice may promote the development of nonreactivity to negative
emotions, distressing cognitions, and visceral sensations. Over time, the cultivation of a
nonreactive mindset may decrease both visceral sensitivity and pain catastrophizing, the
tendency to overemphasize the threat value of the painful stimulus via perseverating on the
affective components of pain. Recent research suggests that MT attenuates activation in
brain areas (i.e., medial prefrontal cortex) that instantiate self-referential, linguistic
processing during negative affective experience while enhancing activation in brain regions
subserving interoception (i.e., insula) (Farb et al., 2010). This pattern of activation suggests
that MT promotes interoceptive recovery from emotional distress, that is, a refocusing from
the affective to viscerosensory aspects of a distressing experience that allows for the
emotion to follow its natural time course and return to baseline, rather than being
perpetuated through rumination (Farb et al., 2010). If mindfulness promotes interoceptive
recovery from negative affective reactions, it may afford a similar interoceptive recovery
from stress-induced physiological perturbations of visceral homeostasis often perceived as
painful by IBS patients. Indeed, reduced cognitive elaboration of the sensory experience of
pain through meditation has been shown to decrease pain unpleasantness (Perlman et al.,
2010). Moreover, given recent findings that affective disturbances like anxiety and
depression mediate the neural processing of visceral pain in IBS (Elsenbruch et al., 2010), it
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is reasonable to suppose that cultivating nonreactivity would decrease anxiety over
abdominal sensations and thereby lead to diminished abdominal pain. In addition, increasing
nonreactivity through MT may reduce pain catastrophizing, which is likely to result in
improved quality of life as IBS symptoms are appraised as more manageable and less
disruptive to psychosocial functioning.
A second hypothesis to account for the beneficial effects of MT on IBS is that MT may alter
the manner in which pain sensations are attended to and processed. MT provides instruction
in breaking down the gestalt of an experience into its phenomenological components
(Strassman & Galanter, 1980). Rather than confront a monolithic (and overwhelming)
experience of “pain,” a practitioner might attend to a sensation of heat localized in the upper
right quadrant of the abdomen, or the tightening of one of the abdominal muscles, and then
notice how this sensation changes over time. This form of interoceptive processing may
attenuate abdominal pain intensity in IBS. Evidence from a number of laboratories suggests
that both brief (Zeidan et al., 2009) and long-term mindfulness meditation (Grant &
Rainville, 2009; Zeidan et al., in press) are associated with decreased pain and increased
pain thresholds during experimental pain stimulation, corroborating findings of decreased
chronic pain in clinical research (Grossman et al., 2004; Rosenzweig et al., 2010).
The aim of the present study was to elucidate the therapeutic mechanisms of a MT
intervention for women with irritable bowel syndrome. We hypothesized that the reduction
in IBS symptoms and improvements in quality of life associated with MT are mediated by
reinterpretation of pain sensations and increased nonreactivity, leading to reductions in
visceral sensitivity and pain catastrophizing (Figure 1). We sought to test the
aforementioned hypotheses in a single multivariate path model that could simultaneously
evaluate the multiple causal pathways outlined above.
MATERIALS AND METHODS
A detailed description of the research protocol was described in previous reports (Gaylord et
al., 2009; Gaylord et al., 2011) and is presented here more succinctly.
Study Participants
Female patients with IBS were recruited from 2006–2009 through advertisements and an
existing registry of IBS patients. Women aged 18–75 years who met Rome II diagnostic
criteria for IBS were included in the study. Individuals with a psychotic disorder or a history
of psychiatric hospitalization in the past two years were excluded, as were participants with
a history of inflammatory bowel disease, celiac disease, gastrointestinal malignancy, liver or
pancreatic disease, or abdominal trauma. Subjects continued to receive usual medical care
for their IBS.
Study Procedure
Study procedures were approved by the institutional review board of the University of North
Carolina at Chapel Hill. Eligible study participants were randomized to either a MT group or
support group (SG). Of the 210 women assessed for eligibility, 97 were found to be eligible,
and were enrolled. Seventy-five (76.5%) began treatment after randomization - 39 in MT
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and 36 in the SG (see the CONSORT diagram in Figure 2). Enrolled subjects met in their
assigned groups for eight weekly two-hour sessions plus one four-hour retreat. Subjects
completed paper-and-pencil questionnaires at baseline and two weeks after the conclusion of
the intervention. Nine subjects withdrew from the study during the intervention, 5 in the MT
group and 4 in the SG (Figure 2).
Mindfulness training intervention
The MT intervention was based on the Mindfulness-Based Stress Reduction (MBSR)
program developed by Jon Kabat-Zinn at the University of Massachusetts. The mindfulness
instructor was a certified professional health coach with approximately 100 hours of post-
baccalaureate education in health coaching, professional training in MBSR from the Center
for Mindfulness at University of Massachusetts, and over ten years of experience teaching
MBSR in clinical settings. The course was typical in length and content, with instruction in
sitting and walking meditations, the body scan technique, and mindful yoga, but was tailored
to address IBS-related concerns. For example, participants were instructed to notice any
sensations in the abdominal area and distinguish those sensations from thoughts about
sensations. In so doing, the mindfulness-training intervention promoted sensory, versus
emotional, processing of interoceptive signals and disengagement from pain catastrophizing.
Homework assigned each week throughout the course included daily mindfulness practices
and psychoeducational readings (Gaylord et al., 2009).
Support Group intervention
For the control intervention, clinical social workers facilitated a support group to control for
expectations of benefit and amount of group contact. A previous clinical trial of CBT for
IBS used a similar support group as a control condition (Payne & Blanchard, 1995). Weekly
sessions focused on IBS-related topics and involved open group discussions about subjects’
experiences with, or reaction to, the topic. Homework assignments consisted of
psychoeducational readings (Gaylord et al., 2009).
Measures
IBS Severity—The Irritable Bowel Symptom Severity Scale (IBS-SS) served as the
primary outcome variable (Francis et al., 1997). On this scale, responders rate
retrospectively, for the past 10 days, abdominal pain severity and frequency (separate
ratings), bloating severity, dissatisfaction with bowel habits and life interference from bowel
symptoms. These five ratings are totaled to obtain an overall IBS severity score. Internal
consistency of the scale in our study sample was acceptable (α = 0.72).
IBS-Related Quality of Life—Changes in physical and psychosocial functioning as a
result of IBS were measured with the IBS-Quality of Life (IBS-QOL) scale, a 34-item scale
that is responsive to therapeutic change (Drossman et al., 2000), and has high test-retest
reliability (Patrick et al., 1998). In the present sample, internal consistency was high (α =
0.95).
Dispositional Mindfulness—We examined the construct of dispositional mindfulness
via the Five Facet Mindfulness Questionnaire (FFMQ; Baer et al., 2006), a validated, 39-
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item Likert-type scale that assesses five internally-consistent factors of mindfulness:
nonreactivity to inner experience (tapped by items such as “I watch my feelings without
getting lost in them”), observing and attending to experience (“I pay attention to sensations,
such as the wind in my hair or the sun on my face”), describing and differentiating
experience (“I’m good at finding words to describe my feelings”), nonjudging of experience
(reverse coded item: “I tell myself I shouldn’t be feeling the way that I am feeling”), and
acting with awareness (reverse coded item: “I find myself doing things without paying
attention”). We focused the present analysis on the nonreactivity subscale of the FFMQ (α =
0.86), to test our hypothesis that nonreactivity would mediate the effect of MT on visceral
sensitivity and pain catastrophizing.
Pain Catastrophizing—Catastrophizing was assessed with the six-item pain
catastrophizing subscale of the Coping Strategy Questionnaire (CSQ) (Rosenstiel & Keefe,
1983), which has been shown to correlate with measures of pain intensity and functional
impairment (Robinson et al., 1997). Items on this scale tap agreement with statements like,
“I feel I can’t stand it anymore,” and “It’s terrible and I feel it’s never going to get any
better.” Internal consistency in this sample was high (α = 0.92).
Visceral Sensitivity—Hypervigilance to visceral sensations and gut-focused anxiety were
assessed with the Visceral Sensitivity Index (VSI), a validated 15-item scale (Labus et al.,
2004). The VSI has been shown to be a strong predictor of symptom severity (Labus et al.,
2004), and evidenced excellent internal consistency in this sample (α = 0.91). For the
purposes of the analyses in this paper, the VSI score was calculated as the numerical sum of
responses to 15 statements pertaining to anticipatory anxiety with respect to the likely
occurrence of distressing gastrointestinal symptoms. As presented in the original scale
validation paper, participants were asked to rate the extent to which they could relate to
these statements using a six-point scale that ranged from 1 = “Strongly agree” to 6 =
“Strongly disagree,” with higher scores indicative of lower visceral sensitivity (Labus et al.,
2004).
Reinterpretation of Pain Sensations—Cognitive coping with pain by reinterpreting
painful sensations as sensory experiences was assessed via the reinterpreting pain sensations
subscale of the CSQ (Rosenstiel & Keefe, 1983). This scale is comprised of items including
“I don’t think of it as pain but rather as a dull or warm feeling,” and “I just think of it as
another sensation such as numbness.” In the present sample, the reinterpretation of pain
sensations subscale demonstrated high internal consistency (α = 0.88).
Psychological Distress—Psychological distress was measured by the Brief Symptom
Inventory-18 (BSI-18) (Derogatis, 2000) The BSI-18 provides separate subscale scores for
anxiety, depression, and somatization, as well a global symptom severity index. Here, the
global severity index, which evidenced high internal consistency (α = 0.87), was used as an
overall measure of psychological distress.
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First, we conducted paired t-tests to examine whether potential mediating variables changed
from pre- to post-intervention within each treatment group. Next, we examined zero-order
correlations between potential mediating and outcome variables, prior to estimating
multivariate path models. Subsequently, multivariate path analysis within a structural
equation modeling framework, which provides simultaneous estimation of multiple linear
equations, was conducted with AMOS 17.0 to examine the direct and indirect relationships
between treatment condition, potential psychological mediators, and therapeutic outcomes.
Path analysis (a) tests the significance of the relationships between variables in a
hypothetical model and (b) compares alternative models to determine which model best fits
the observed data. The starting point for the specification of the measures and paths in our
models was based on theory, as outlined in our original study proposal.
We screened all the potential variables that were candidate mediators of the effects of MT
on IBS severity and IBS-related quality of life and dropped those which showed no
difference between MT and SG and those which were not significantly correlated with IBS
severity or quality of life. Although our theoretical model was centered on nonreactivity as a
key therapeutic mechanism of mindfulness, we sought to determine if other FFMQ facets
were integral mediating the effects of MT on cognitive risk factors (i.e., visceral sensitivity
and catastrophizing) for IBS severity and impaired quality of life. As such, we examined
correlations between FFMQ facets and the other study variables. In addition to
nonreactivity, nonjudgment and acting with awareness were significantly associated with
changes in visceral sensitivity and catastrophizing (r’s = .30 – .46; p’s < .05). Because there
were no significant between-groups differences in nonjudgment (p = .18), this facet was
rejected as a unique mediator of MT on IBS-related clinical outcomes. Further, neither the
MT group nor the SG reported significant increases in acting with awareness, and thus this
mindfulness facet could also not serve as a mediator the effects of MT on IBS-related
clinical outcomes.
Consequently, our initial hypothetical model focused on nonreactivity and excluded the
other 4 facets in the FFMQ. This simplified theoretical model is shown in Figure 1. The
final model was generated using a data-driven approach to achieve the best model fit, where
we examined correlation matrices for data suggesting that our a priori model had omitted
important paths, and trimmed nonsignificant paths to improve model fit using the chi-square
difference test to evaluate the comparative parsimony of nested models (Kline, 1998).
Subjects in both study arms (MT and SG) were included in path analyses. A dummy
variable representing the MT versus the SG treatment conditions was created (where 1 = MT
and 0 = SG) and was used as the independent (exogenous) variable in multivariate path
analyses. Pre-post treatment change scores were used for all endogenous variables (Maris,
1998; Rogosa, 1988). Figure 1 depicts our main hypothetical model. Treatment condition
was hypothesized to exert indirect effects on changes in IBS severity, as we hypothesized
that MT would result in decreased abdominal pain through two main pathways: a) by
increasing nonreactivity, resulting in decreased visceral sensitivity over the course of
treatment; and b) by increasing reinterpretation of pain sensations, also resulting in
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decreased visceral sensitivity. Similarly, treatment condition was modeled to exert indirect
effects on changes in IBS-related quality of life, potentially mediated by changes in visceral
sensitivity, pain catastrophizing, and IBS severity.
We also tested a series of four alternative models. In model two we conducted a partial
mediation model where treatment condition had both direct and indirect effects on treatment
changes in IBS severity and IBS-related quality of life. This model proposed that treatment
(i.e., mindfulness training) could directly reduce IBS severity and increase IBS-related
quality of life in addition to influencing these outcomes indirectly via pathways through
nonreactivity, reinterpretation of pain sensations, visceral sensitivity, and pain
catastrophizing.
Next, because it is commonly assumed that psychological interventions ameliorate IBS
symptoms by reducing psychological symptoms, we tested model three where changes in
psychological distress could potentially mediate the treatment effect. This competing
hypothesis was reasonable given the body of literature demonstrating therapeutic effects of
mindfulness practice on psychological distress (e.g., Jones et al., 2011, Lackner et al., 2007),
as well as our own findings of significantly improved psychological distress among IBS
patients at follow-up (Gaylord et al., 2011).
Lastly, because our hypothetical model, like all causal models, is prone to specification
error, two other alternative models were assessed to ensure that significant path coefficients
identified were not artifactual. A priori, we reasoned that reductions in catastrophizing
would be more directly linked with IBS-related quality of life than IBS severity, given that
catastrophizing has been robustly associated with quality of life among IBS patients (Seres
et al., 2008). To test this assumption, we ran model four, with a path between change in
catastrophizing and change in IBS severity rather than IBS-related quality of life.
Furthermore, we presumed a priori that because the mindfulness intervention offered
explicit training in reinterpretation of pain sensations as a distinct technique from the
cultivation of nonreactivity to thoughts and emotions, there would be a direct pathway from
the treatment variable to change in reinterpretation of pain sensations. To confirm this
assumption, we tested model five where the effect of treatment on change in reinterpretation
of pain sensations was indirectly mediated by change in nonreactivity.
Because we found that sociodemographic (age, education, and race) variables were
statistically unrelated to IBS severity and quality of life in the present sample, they were
omitted from path analyses for the purposes of parsimony.
AMOS 17.0 was used to calculate model parameters, and missing data were handled using
full-information maximum likelihood estimation. Model fit was determined comparing fit
indices to widely accepted cut-offs (Kline, 1998), including nonsignificant χ2 (p > .05),
comparative fit index (CFI) > 0.90, and the root-mean square error of approximation
(RMSEA) < 0.08.
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Characteristics of the study sample are provided in Table 1. There were no significant
differences between MT and SG participants on any of the demographic variables. In
addition, descriptive statistics for MT and SG groups on changes in clinical outcomes and
the hypothesized cognitive-affective mediators of the treatment effects are shown in Table 2.
Participants in the MT group experienced significant improvements in IBS severity, IBS-
related quality of life, nonreactivity, nonjudgment of experience, observing and attending to
experience, visceral sensitivity, pain catastrophizing, psychiatric distress, and cognitive
coping via reinterpretation of pain sensations from pre- to post-treatment. In contrast, no
significant changes were observed among SG participants. Zero-order correlations between
primary study variables are presented in Table 3.
Test of the hypothesized model
Model one: full mediation model—Our hypothesized model (Figure 1) exhibited good
fit: χ2/df = 1.26, p = .24; RMSEA = .05 (.00, .13), CFI = .96, AIC = 61.83. Results indicated
that the therapeutic effect of MT on IBS severity was mediated by increasing
reinterpretation of pain sensations and decreasing visceral sensitivity, the latter being
mediated, in turn, by improvements in nonreactivity. Similarly, increases in nonreactivity
mediated reductions in pain catastrophizing, which, along with reductions in visceral
sensitivity and IBS severity, mediated improvements in IBS-related quality of life. However,
the pathway between change in reinterpretation of pain sensations and visceral sensitivity
was not significant. As such, we trimmed this pathway, and achieved a better model fit: χ2/df
= 1.15, p = .31; RMSEA = .04 (.00, .12), CFI = .98, AIC = 59.83. Given that these models
were nested (i.e., the second model without the path between change in reinterpretation of
pain sensations and visceral sensitivity is a subset of the first model), a chi-square difference
test was employed for model comparison, χD2 = χ2 (m2) - χ2 (m1), with dfD = df(model 2)-
df(model 1), where a significant χD2 value indicates that the trimmed model is
oversimplified (Kline, 1998). The non-significant chi-square value obtained (p = .86)
indicated that trimmed model was most parsimonious. Given that this model (Figure 2) was
more parsimonious and fit our a priori hypotheses, we henceforth report its parameter
estimates in detail.
Mediation of the effect of MT on IBS severity—MT was significantly associated with
increases in reinterpretation of pain sensations (β = .34, p < .01) and increases in
nonreactivity (β = .29, p < .05). Additionally, increased nonreactivity was associated with
decreased visceral sensitivity (β = .48, p < .001) and pain catastrophizing (β = .33, p < .01).
In turn, decreased visceral sensitivity and (β = .26, p < .05) and increased reinterpretation of
pain signals (β = .29, p < .05) were significantly associated with reduced IBS severity. The
path model accounted for 16% of the variance in improvements in IBS severity.
Mediation of the effect of MT on IBS-related quality of life—There was a direct
relationship between decreased IBS severity and improved IBS-related quality of life (β = .
28, p = .002), which indicated that reductions in IBS severity over the course of the MT
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intervention predicted increases in quality of life. In addition, decreases in visceral
sensitivity (β = .39, p < .001) and pain catastrophizing (β = .45, p < .001) over the course of
treatment were associated with increased IBS-related quality of life. The path model
accounted for 56% of the variability in improvements in quality of life.
Tests of alternative models
Model two: partial mediation model—We first tested an alternative, partial mediation
model where intervention condition had both direct and indirect effects on IBS severity and
IBS-related quality of life. This model also demonstrated good fit, χ2/df = 1.15, p = .32;
RMSEA = .04 (.00, .12), CFI = .98, AIC = 61.48. Given that the model with only indirect
effects of treatment was a subset of an alternate model with both direct and indirect effects
of treatment, another chi-square difference test was employed for model comparison. The
non-significant chi-square value obtained (p = .31) indicated that the additional direct effects
of MT on IBS severity and IBS-related quality of life should not be retained in the final
model, and that a full mediation model with only indirect effects of MT on IBS severity and
IBS-related quality of life was more parsimonious.
Model three: psychological distress as a mediator—Although changes in
reinterpretation of pain sensations, nonreactivity, visceral sensitivity, and catastrophizing
were found to mediate the effects of MT, decreased IBS severity, and increased IBS-related
quality of life, competing models explicating the pathways between these variables are
possible. Given intervention effects on psychological distress observed in clinical outcomes
research on MT for IBS (Gaylord et al., 2011) and in the studies of Lackner et al. (2007) and
Jones et al. (2011) on cognitive-behavioral therapy for IBS, we next tested an alternative
path model where changes in psychological distress could mediate the effect of MT on IBS-
related quality of life. This model exhibited acceptable fit: χ2/df = 1.25, p = .23; RMSEA = .
06 (.00, .13), CFI = .95, AIC = 77.47. However, in this model, after controlling for all of the
aforementioned variables, pathways between MT and changes in psychological distress and
IBS-related quality of life were statistically nonsignificant. Upon comparing fit indices of
these two models, our original hypothetical model exhibited superior fit to the alternative
model.
Models four and five—Neither of the other two alternative models fit the data as well as
the final model presented in Figure 3 (model four: χ2/df = 2.69, p = .001; RMSEA = .13 (.
08, .19), CFI = .74, AIC = 78.28; model five: χ2/df = 1.74, p = .05; RMSEA = .09 (.00, .15),
CFI = .89, AIC = 66.83), nor did the parameter estimates derived contradict the basic
conclusions made in the results and discussion sections of this paper. Hence, we do not
present parameters of these alternative models. Given the presence of nonsignificant paths
and decrements in model fit, our original (yet trimmed) hypothetical model was retained as
the final model. The final model is presented in Figure 3 and Table 4.
DISCUSSION
Our research suggests that MT substantially attenuates IBS symptoms and ameliorates the
often severe impairments in quality of life that characterize this disorder (Gaylord et al.,
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2011). Results of the path analyses in the present investigation indicate that these therapeutic
effects were mediated by a number of cognitive processes with known associations to the
affective and sensory antecedents and consequences of pain. MT led to increased
nonreactivity to cognitions, emotions, and physiological sensations which in turn was
associated with decreased visceral sensitivity. Reductions in visceral sensitivity predicted
decreased severity of IBS symptoms and improved IBS-related quality of life. In addition,
increases in nonreactivity were associated with decreases in pain catastrophizing which also
predicted improvements in quality of life. MT also led to increases in reinterpretation of pain
sensations which predicted reductions in IBS severity. Overall, reduced IBS severity
mediated improvements in IBS-related quality of life.
With regard to both IBS severity and the effect of IBS on quality of life, cultivating a
nonreactive mindset toward potentially distressing thoughts, affective states, and somatic
symptoms appears to be a key process. Based on our path analyses, it appears that as IBS
patients learn through MT to let go of visceral sensations and their worried thoughts about
such sensations and observe them with a dispassionate attentional stance, anxiety over
sensations of gastrointestinal distention decreases, leading to reductions in abdominal pain
and IBS-related impairments in quality of life. This causal pathway identified in our analysis
may be subserved by the same brain mechanisms that underlie the neuromodulatory effects
of anxiety on visceral hyperalgesia (Elsenbruch et al., 2010). Cultivating nonreactivity may
also lead to less catastrophic primary appraisals of the threat value of painful sensations in
the gut while increasing veracity of secondary appraisals of one’s ability to manage those
sensations. Such mindfulness-related reductions in catastrophizing may thereby lessen
impairments in psychosocial functioning secondary to IBS, as patients come to realize that
they can successfully cope with unpleasant gastrointestinal symptoms without substantial
disruption of their everyday lives.
Moreover, evidence from experimental and clinical studies demonstrates that negative mood
induction increases pain perception via emotion-based tuning of the pain neuromatrix
(Wiech & Tracey, 2009). Conversely, neuromodulatory activations of anterior cingulate
cortex (ACC) and lateral prefrontal cortex (PFC) are associated with decreases in pain
resulting from cognitive interventions that promote detachment from the affective
components of pain (Kalisch et al., 2005). It is possible that the nonreactive awareness
engendered by MT may influence the affective modulation of pain via increases in lateral
PFC and ACC activity, brain structures which appear to subserve hypnosis-induced
decreases in pain unpleasantness (Rainville et al., 1997). Although hypnosis is often used to
facilitate dissociation from pain whereas MT encourages “being with” pain, both
interventions share a component of attentional refocusing and detachment from affective
reactions to noxious stimuli.
Concomitantly, reinterpretation of pain sensations as sensory signals, taught as part of the
MT, appears to be another key mechanism underlying the therapeutic effect of the
intervention on IBS symptoms. During the 8-week course of MT, IBS patients were
instructed to attend to the sensory qualities of their visceral sensations rather than their
thoughts about such sensations. Mindfully engaging attention toward gastrointestinal
symptoms may objectify visceral sensations as innocuous sensory data rather than as an
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emotionally salient threat to physical wellbeing (Farb et al., 2010). By coping with
abdominal pain in this manner, cognitive elaboration on the unpleasantness of pain is
reduced while attention to interoceptive signals is increased. Such a shift from affective to
sensory processing may result in interoceptive recovery from experiences of emotional
distress stemming from abdominal pain. Indeed, a recent study of the effect of mindfulness
on experimentally induced pain found that meditation-related decreases in pain intensity
were associated with increased activation of the ACC and anterior insula (Zeidan et al., in
press), brain regions that putatively may subserve the process of interoceptive recovery.
Without brain imaging data, the foregoing, proposed linkages between therapeutic processes
and neurocognitive mechanisms are merely informed speculations. Yet, current study
findings robustly confirm a priori hypotheses about the ways in which MT operates to
ameliorate somatic symptoms.
The present findings should be considered in light of several studies that investigated the
therapeutic mechanisms of CBT for IBS. Lackner and colleagues (2007) identified a
feedback loop between changes in psychological distress and IBS-related quality of life.
Jones et al. (2009) identified indirect effects of CBT on IBS symptoms that were partially
mediated by changes in anxiety and depression. In contrast, we found no significant
relationship between changes in psychological distress and IBS-related quality of life after
controlling for the influence of pain catastrophizing and visceral sensitivity. One explanation
for this discrepancy may be that CBT and MT operate through distinct therapeutic
mechanisms, where the former targets distressing cognitive-emotional content while the
latter targets a maladaptive cognitive-emotional process (Hayes & Wilson, 2003), that is,
conflating cognitive evaluations of sensory experience with the actual experience in and of
itself. Indeed, two key therapeutic mechanisms identified in the present investigation,
nonreactivity and reinterpretation of pain sensations, are both process-level factors. These
factors relate to pre-verbal, nonconceptual modes of cognitive processing that appear to be
opposed to the strong affective reactions to visceral stimuli characteristic of IBS patients.
Yet, despite these possible differences, MT and CBT may target some similar processes. For
example, RCTs have found that participation in CBT is associated with significant
reductions in visceral sensitivity and catastrophizing (Craske, Wolitzky-Taylor, Labus, Wu,
Frese, Mayer, & Naliboff, 2011; Hunt, Mosier, & Millanova, 2009).
This study has substantial strengths, including the simultaneous estimation of multiple
causal pathways and outcomes within the same model and the use of an active and credible
control condition. There are also a number of limitations. The sample size precluded the use
of latent variables in our structural equation models, and thus, although the study utilized
well-validated measures, the inclusion of manifest variables in the analyses may have biased
statistical estimates due to measurement error. Future research should use questionnaire
items as indicators to model the latent constructs of interest (e.g., nonreactivity, pain
catastrophizing, etc.). Second, although our overall model fit was excellent, the specified
pathways explained only a modest (yet statistically significant) amount of variance in IBS
severity, which implies that variables were omitted from the present investigation that may
have contributed significantly to the therapeutic effect of mindfulness on IBS. A third
primary limitation of the study relates to its reliance on self-report data. Future
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investigations should incorporate behavioral, psychophysiological, and neuroimaging
measures to counter social desirability biases and further parse the mechanisms
underpinning the robust treatment effects observed. Finally, the present investigation cannot
establish causal order of putative treatment mechanisms and changes in IBS severity. For
causality to be established, changes in the mediator must precede changes in the dependent
variable of interest (Baron & Kenny, 1986). Pre-post changes in reinterpretation of pain
sensations, nonreactivity, visceral sensitivity, IBS severity, and IBS-related quality of life
were measured concurrently and thus true causal order of the hypothesized pathways cannot
be ascertained. Future research should employ an even greater number of measurement
points to allow for greater precision in identifying mediational pathways. The results of path
analysis are “data driven,” that is, dependent on the particular set of experimental
observations to support the explanatory model. Because of this, study findings should be
considered exploratory and require replication in additional samples of subjects.
Earlier, we (2007; Garland et al., 2009) asserted that disengagement from negative
appraisals of aversive stimuli in favor of attending to the raw sensorium of present moment
experience allows for the generation of new, more adaptive appraisals rather than
reprocessing an existing cognitive set already tainted by negative emotional judgments. In
the present data, we see traces of this hypothetical mechanism. MT appears to result in
nonreactivity to gut-focused anxiety and catastrophic appraisals of the significance of
abdominal sensations coupled with a refocusing of attention onto interoceptive data with
less affective interference. By learning to mindfully disengage from negative cognitive
appraisals of visceral sensations and re-orient attention to the sensory quality of
interoceptive experience, IBS patients may come to appraise such sensations as innocuous
and eminently manageable.
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Theoretical model of the therapeutic mechanisms of mindfulness training on
cognitiveaffective mediators of IBS severity and IBS-related quality of life. Solid arrows
represent amplification, whereas dashed arrows represent attenuation.
Garland et al. Page 17
























Garland et al. Page 18























Path model (N = 75) testing mediational relationships between mindfulness training,
reinterpretation of pain sensations, visceral sensitivity, nonreactivity, pain catastrophizing,
IBS severity, and IBS-related quality of life.
Garland et al. Page 19




























































































































































































































































































































































































































































































































Garland et al. Page 21
Table 2
Pre-post treatment changes in clinical outcomes and hypothesized cognitive-affective mediators of the
treatment effects.
Variable
Change in score: Mindfulness Group Change in score: Support Group
Mean S.D. Mean S.D.
IBS severity −82.0*** 97.1 −22.5 88.7
IBS-quality of life 11.2*** 15.9 4.4 16.7
Visceral sensitivity −6.3** 11.7 −1.5 14.2
Pain catastrophizing −3.5** 6.2 −2.9 8.1
Reinterpreting pain sensations 4.4*** 5.5 0.8 4.7
Nonreactivity 2.7** 4.6 0.1 4.2
Nonjudging of experience 3.7** 7.7 1.4 5.8
Acting with awareness 0.7 5.2 1.2 4.7
Observing/attending to experience 2.9** 4.2 −0.2 3.3
Describing/differentiating experiences 1.0 3.9 0.5 4.9
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Table 4
Parameter estimates for the final model of the therapeutic effect of mindfulness training on IBS severity and
quality of life.
Path Coefficient Unstandardized beta Standard error p
Mindfulness training → Δ reinterpretation .34 3.62 1.33 .006
Mindfulness training → Δ nonreactivity .29 2.59 1.11 .02
Δ Nonreactivity → Δ visceral sensitivity −.48 1.37 .33 <.001
Δ Nonreactivity → Δ catastrophizing .33 .52 .20 .008
Δ Reinterpretation → Δ IBS severity .29 5.26 2.16 .02
Δ Visceral sensitivity → Δ IBS severity −.26 1.93 .87 .03
Δ Catastrophizing → Δ IBS-related quality of life .45 1.03 .20 <.001
Δ Visceral sensitivity → Δ IBS-related quality of life −.39 −.49 .11 <.001
Δ IBS severity → Δ IBS-related quality of life .28 .05 .02 .002
Δ = change from pre- to post-treatment levels. Total R for change in IBS severity from pre- to post-treatment = .15; Total R2 for change in IBS-
related quality of life from pretreatment to 3-month follow-up = .56
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